Fundraising FoxTalon Therapeutics
San Mateo, US
Find your way into Talon Therapeutics
Sign up to see every warm intro you have to Talon Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Talon Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
CW
Craig W. CarlsonExecutive
SR
Steven R. Deitcher, M.D.Executive
SM
Samir M. GharibExecutive
Board
JL
Jonathan LeffBoard director
HP
Howard P. Furst, M.D.Board director
CG
Cecilia GonzaloBoard director
AF
Andrew FerrerBoard director
PV
Paul V. MaierBoard director
LE
Leon E. Rosenberg, M.D.Board director
RJ
Robert J. SpiegelBoard director
Reported raises · per SEC filings
Form D private placements$10.6M disclosed across 2 rounds · 2012
▶$10.3MraisedJan 2012 · 4 investors · BiotechnologyRule 506(b)
▶$10.3MraisedJan 2012 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Craig W. CarlsonExecutive Officer
- Jonathan LeffDirector
- Howard P. Furst, M.D.Director
- Paul V. MaierDirector
- Cecilia GonzaloDirector
- Leon E. Rosenberg, M.D.Director
- Andrew FerrerDirector
- Robert J. SpiegelDirector
- Steven R. Deitcher, M.D.Executive Officer, Director
- Samir M. GharibExecutive Officer
- Offering amount
- $70.4M
- Amount sold
- $10.3M
- Sales commissions
- $200K
- Placement agents
- Roth Capital Partners, LLC
- First sale
- Jan 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
▶$258KraisedJan 2012 · 2 investors · BiotechnologyRule 506(b)
▶$258KraisedJan 2012 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Craig W. CarlsonExecutive Officer
- Leon E. Rosenberg, M.D.Director
- Steven R. Deitcher, M.D.Executive Officer, Director
- Paul V. MaierDirector
- Samir M. GharibExecutive Officer
- Robert J. SpiegelDirector
- Cecilia GonzaloDirector
- Jonathan LeffDirector
- Howard P. Furst, M.D.Director
- Andrew FerrerDirector
- Offering amount
- $2.3M
- Amount sold
- $258K
- First sale
- Jan 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Talon Therapeutics raised?
- Talon Therapeutics has disclosed $10.6M raised across 2 rounds.
- Where is Talon Therapeutics headquartered?
- Talon Therapeutics is headquartered in San Mateo, US.